OncoDaily News

NRG1

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Facebook
RSS
X
Youtube
Linkedin
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Apr    

NRG1

May 6, 2025, 11:07 | Science
Diego A. Díaz García: HER3 - From Understudy to Key Target
Diego A. Díaz García, Medical Oncologist , CEO and Founder at CánCare, shared an article on…
Mar 3, 2025, 12:41 | Drugs
Zenocutuzumab: Uses in Cancer, Side Effects, Dosages, Expectations, and More
Zenocutuzumab (Zeno, MCLA-128) is a bispecific monoclonal antibody. It targets HER2 and HER3 receptors to…
Feb 22, 2025, 11:02 | Oncolibrary
New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
Zenocutuzumab, a bispecific HER2/HER3 antibody, has emerged as a promising treatment for patients with NRG1…
Dec 12, 2024, 13:14 | Blog
Razelle Kurzrock: Targeting NRg1 fusions
Razelle Kurzrock, Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center,…
May 23, 2024, 11:18 | Insight
Top 5 articles of the week in Cancer Network
Cancer Network shared on X: "View the top 5 articles of the week: FDA Approves…
Apr 25, 2024, 20:06 | Blog
Jacob Adashek: Comparing and contrasting Figures 1 from NRG1 papers from 2020 Clinical Cancer Research of AACR and 2024 BMC Medicine from our paper
Jacob Adashek, Medical Oncology Fellow at the Sidney Kimmel Comprehensive Cancer Center, shared on X/Twitter:…
All: 6 Posts: 1 - 100
'
Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
'
Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025
'
USA vs Europe: Who Does Cancer Screening Better?
'
A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
'
Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals
Special Coverage
  • Challenging the Status Quo in Colorectal Cancer 2024
    December 6-8, 2024
  • ESMO 2024 Congress
    September 13-17, 2024
  • ASCO Annual Meeting
    May 30 - June 4, 2024
  • Yvonne Award 2024
    May 31, 2024
  • OncoThon 2024, Online
    Feb. 15, 2024
  • Global Summit on War & Cancer 2023, Online
    Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube
OncoDaily ™  |  © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of the content on OncoDaily.com is strictly prohibited.
For permission requests or inquiries, contact OncoDaily. By accessing and using OncoDaily.com, you agree to comply with this copyright notice.

E-Mail: [email protected], Tel: +1 978 7174884

About us OncoDaily Pulse Privacy Policy Editorial Policy Cookie Policy Disclaimer
OncoDaily Oncology cancer fight against cancer Global fight against cancer cancer care Breast Cancer ASCO Lung cancer Cancer research MD Anderson Cancer Center cancer awareness ESMO ASCO24 Research cancer treatment NSCLC immunotherapy Headlines AACR prostate cancer Childhood Cancer colorectal cancer clinical trials FDA Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation UICC National Cancer Institute NCI healthcare SIOP chemotherapy Vivek Subbiah WHO AI Zainab Shinkafi-Bagudu American Society of Clinical Oncology Memorial Sloan Kettering Cancer Center Paolo Tarantino multiple myeloma American Association for Cancer Research cervical cancer patient care Robert Orlowski radiation oncology IASLC Sylvester Comprehensive Cancer Center Pancreatic Cancer Sitemap All Tags »